LENSAR, Inc. (LNSR)

NasdaqCM - NasdaqCM Real-time price. Currency in USD

Add to watchlist

3.0500

+0.1100

(+3.74%)

At close: 04:00PM EST

Loading interactive chart…

Business Wire
LENSAR to Present at Two Upcoming Investor Conferences
ORLANDO, Fla., November 22, 2022--LENSAR, Inc. (NASDAQ: LNSR) ("LENSAR" or "the Company"), a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment of cataracts, today announced Nick Curtis, Chief Executive Officer will present at two upcoming investor conferences:
Business Wire
LENSAR Reports Third Quarter 2022 Financial Results and Provides Business Update
ORLANDO, Fla., November 09, 2022--LENSAR, Inc. (Nasdaq: LNSR) ("LENSAR" or "the Company"), a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment of cataracts, today announced financial results for the quarter ended September 30, 2022 and provided a business update.
Business Wire
LENSAR to Report Third Quarter 2022 Financial Results on Wednesday, November 9, 2022
ORLANDO, Fla., November 02, 2022--LENSAR, Inc. (Nasdaq: LNSR) ("LENSAR" or "the Company"), a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment of cataracts, today announced that the Company’s third quarter 2022 financial results will be released before market open on Wednesday, November 9, 2022. LENSAR’s management will host a conference call and webcast at 8:30 am ET on Wednesday, November 9, 2022 to discuss the financial results and re